Peptide Reconstitution Calculator: How Much Bac Water to Add

Every lyophilized peptide vial follows the same reconstitution math. The concentration formula, the dose-volume calculation, and the syringe-unit conversion are universal — they do not change between compounds. What changes is the vial size, the target dose range, and the bacteriostatic water volume chosen to hit a convenient concentration.

Research-context information only. The peptides referenced below include compounds sold for research purposes only as well as active ingredients in FDA-approved medications. Protocols, doses, and reconstitution ratios reported here come from clinical trial documentation, manufacturer references, and self-reported community sources. This article reports what has been documented, not what should be done. Consult a licensed physician for personal medical decisions.

This guide reports the universal formula, pre-calculated lookup tables for every common vial size, and worked examples for specific peptides documented in community reconstitution references.

The universal reconstitution formula

Two equations cover every peptide reconstitution scenario. Community reconstitution sheets, vendor instruction inserts, and clinical trial protocols all derive from the same underlying math.

Step 1 — Concentration:

Concentration (mg/mL) = Peptide amount (mg) ÷ Bacteriostatic water volume (mL)

Step 2 — Dose volume:

Volume to inject (mL) = Desired dose (mg) ÷ Concentration (mg/mL)

Step 3 — Syringe units (U-100 insulin syringe):

Units on syringe = Volume (mL) × 100

A U-100 insulin syringe reads 100 units per 1 mL. So 0.1 mL = 10 units, 0.25 mL = 25 units, 0.5 mL = 50 units. Community sources cite this conversion as the bridge between the concentration math and the practical measurement step.

Lookup tables by vial size

The tables below report pre-calculated concentrations for every common vial size and bacteriostatic water volume combination documented across community reconstitution references. Each table also shows the syringe units required for selected dose amounts.

5 mg vial

Community sources most frequently cite 2 mL for 5mg vials. The 2.5 mg/mL concentration produces dose volumes that land on round syringe marks for common peptide protocols.

10 mg vial

For 10mg vials, community reconstitution sheets commonly cite 2 mL (producing 5 mg/mL) or 5 mL (producing 2 mg/mL) depending on whether measurement precision or smaller injection volume is prioritized.

15 mg vial

Community sources citing GLP-1 receptor agonist reconstitution frequently reference the 6 mL ratio for 15mg vials — the resulting 2.5 mg/mL concentration matches the standard cited for 5mg vials reconstituted with 2 mL.

20 mg vial

The 20mg vial size appears in community sources for retatrutide and some higher-volume research peptides. Community references commonly cite 4 mL for a clean 5 mg/mL concentration or 8 mL for the 2.5 mg/mL standard.

30 mg vial

The 30mg format appears in community sources for bulk research vials. At this vial size, higher concentrations (3 mL or 6 mL water) are more commonly cited because lower concentrations would require volumes exceeding a standard 1 mL insulin syringe for larger doses.

Peptide-specific examples

The universal formula applies to every lyophilized peptide. The difference between compounds is the dose range documented in community protocols and clinical trial literature. The examples below show how the same concentration math maps to peptide-specific dosing.

BPC-157

Community protocols most commonly describe doses in the 250 to 500 mcg range, administered once or twice daily. BPC-157 is sold in 5mg and 10mg vial formats across community vendor sources.

5mg vial + 2 mL bac water = 2.5 mg/mL:

• 250 mcg = 10 units on a U-100 syringe
• 500 mcg = 20 units

At this concentration, a 5mg vial contains 10 doses at 500 mcg or 20 doses at 250 mcg — community sources cite this as sufficient for a 10 to 20 day protocol at once-daily dosing.

Semaglutide

Clinical trial documentation describes a titration from 0.25 mg weekly up to 2.4 mg weekly. Research-format semaglutide is sold in 5mg, 10mg, and 15mg vial formats.

5mg vial + 2 mL bac water = 2.5 mg/mL:

• 0.25 mg = 10 units
• 0.5 mg = 20 units
• 1 mg = 40 units
• 2.4 mg = 96 units

Community reconstitution sheets most commonly cite the 2 mL ratio for semaglutide because every documented titration step falls within a single 100-unit syringe at 2.5 mg/mL.

Tirzepatide

Clinical trial protocols describe a titration from 2.5 mg weekly up to 15 mg weekly. Research-format tirzepatide is sold in 5mg, 10mg, 15mg, and 30mg vial formats.

10mg vial + 2 mL bac water = 5 mg/mL:

• 2.5 mg = 50 units
• 5 mg = 100 units (full syringe)

30mg vial + 6 mL bac water = 5 mg/mL:

• 2.5 mg = 50 units
• 5 mg = 100 units
• 7.5 mg = requires 1.5 mL (exceeds a 1 mL syringe — community sources describe drawing in two pulls or using a larger syringe format)

Community sources note that tirzepatide doses above 5 mg at 5 mg/mL exceed a standard 1 mL insulin syringe. Higher-concentration reconstitutions (10 mg/mL with 3 mL water in a 30mg vial) are cited in community references for users on maintenance doses above 5 mg.

Retatrutide

Clinical trial documentation describes a titration from 1 mg weekly up to 12 mg weekly. Research-format retatrutide is sold in 10mg and 20mg vial formats.

20mg vial + 4 mL bac water = 5 mg/mL:

• 1 mg = 20 units
• 2 mg = 40 units
• 4 mg = 80 units

20mg vial + 2 mL bac water = 10 mg/mL:

• 4 mg = 40 units
• 8 mg = 80 units
• 12 mg = 120 units (exceeds a 1 mL syringe)

Community reconstitution references for retatrutide frequently note the syringe-volume constraint at higher doses. The 4 mL ratio is commonly cited for the titration phase (1 to 4 mg), while some sources describe switching to a 2 mL ratio or using a 3 mL syringe at maintenance doses above 5 mg.

Why bacteriostatic water volume matters

The amount of bacteriostatic water added to a vial does not change the total peptide content — it changes the concentration, which changes the volume drawn per dose. Community sources consistently describe three trade-offs that inform the choice:

More water (lower concentration):

• Larger injection volumes per dose
• Easier to measure small doses accurately on a U-100 syringe
• Vial depleted in fewer doses if the injection volume approaches 1 mL per dose
• Community sources cite this as the better choice for peptides dosed in the microgram range (BPC-157, GHK-Cu, melanotan) where measurement precision matters most

Less water (higher concentration):

• Smaller injection volumes per dose
• Harder to measure very small doses — a 1-unit error represents a larger percentage of the intended dose
• More doses per vial before depletion
• Community sources cite this as the better choice for peptides dosed in the milligram range (semaglutide at 2.4 mg, tirzepatide at 5+ mg) where injection volume becomes the limiting factor

The 28-day constraint: USP guidance describes a 28-day multi-dose window for bacteriostatic water under aseptic technique. Regardless of concentration, the vial should be used within 28 days of reconstitution. Community sources cite this as the ceiling — choosing a concentration that matches the expected number of doses within 28 days avoids waste.

Common reconstitution errors documented in community sources

Community reconstitution references and forum discussions consistently flag the same set of errors:

1. Injecting water directly onto the powder. Community sources describe aiming the needle at the vial wall so the water rolls down gently rather than hitting the lyophilized cake directly. Direct-stream reconstitution is cited as a cause of foaming and potential peptide denaturation.

2. Shaking the vial. Gentle swirling is the universally documented dissolution technique. Shaking is cited in community sources as a cause of peptide aggregation, visible particulates, and reduced potency.

3. Confusing units with milligrams. A U-100 syringe measures volume in units (100 units = 1 mL), not peptide mass. The units-to-milligrams conversion depends entirely on the reconstitution concentration. Community sources cite this confusion as the most common dosing error.

4. Using sterile water instead of bacteriostatic water for multi-dose vials. Sterile water for injection contains no preservative and carries a 24-hour use window after first puncture. Bacteriostatic water (0.9% benzyl alcohol) supports the 28-day multi-dose window. Community sources cite this substitution as safe only for single-use vials consumed in one draw.

Quick-reference: concentration at a glance

For fast lookup, the table below reports concentration values for every vial-size and water-volume combination in a single grid.

The formula behind every cell: peptide amount divided by water volume. Community reconstitution references pre-calculate these values, but the underlying math is the same single division in every case.